Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1T315I+ clones in TKI-resistant CML.
Schneeweiss-Gleixner M, Byrgazov K, Stefanzl G, Berger D, Eisenwort G, Lucini CB, Herndlhofer S, Preuner S, Obrova K, Pusic P, Witzeneder N, Greiner G, Hoermann G, Sperr WR, Lion T, Deininger M, Valent P, Gleixner KV. Schneeweiss-Gleixner M, et al. Among authors: lion t. EBioMedicine. 2019 Dec;50:111-121. doi: 10.1016/j.ebiom.2019.11.004. Epub 2019 Nov 21. EBioMedicine. 2019. PMID: 31761618 Free PMC article.
Decontamination of High-Efficiency Mask Filters From Respiratory Pathogens Including SARS-CoV-2 by Non-thermal Plasma.
Obrová K, Vaňková E, Sláma M, Hodek J, Khun J, Ulrychová L, Nogueira F, Laos T, Sponseiler I, Kašparová P, Machková A, Weber J, Scholtz V, Lion T. Obrová K, et al. Among authors: lion t. Front Bioeng Biotechnol. 2022 Feb 14;10:815393. doi: 10.3389/fbioe.2022.815393. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35237577 Free PMC article.
Presence of viremia during febrile neutropenic episodes in patients undergoing chemotherapy for malignant neoplasms.
Obrová K, Grumaz S, Remely M, Czurda S, Krickl I, Herndlhofer S, Gleixner KV, Sperr WR, Größlinger L, Frank T, Andrade N, Egger-Matiqi T, Peters C, Engstler G, Dworzak M, Attarbaschi A, van Grotel M, van den Heuvel-Eibrink MM, Moiseev IS, Rogacheva Y, Zubarovskaya L, Zubarovskaya N, Pichler H, Lawitschka A, Koller E, Keil F, Valent P, Sohn K, Lion T. Obrová K, et al. Among authors: lion t. Am J Hematol. 2021 Jun 1;96(6):719-726. doi: 10.1002/ajh.26177. Epub 2021 May 3. Am J Hematol. 2021. PMID: 33784434 Free article.
Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1 T315I-compound mutations.
Gleixner KV, Filik Y, Berger D, Schewzik C, Stefanzl G, Sadovnik I, Degenfeld-Schonburg L, Eisenwort G, Schneeweiss-Gleixner M, Byrgazov K, Sperr WR, Mayer J, Lion T, Valent P. Gleixner KV, et al. Among authors: lion t. Am J Cancer Res. 2021 Sep 15;11(9):4470-4484. eCollection 2021. Am J Cancer Res. 2021. PMID: 34659899 Free PMC article.
Prevalence and clinical course of viral upper respiratory tract infections in immunocompromised pediatric patients with malignancies or after hematopoietic stem cell transplantation.
Fazekas T, Eickhoff P, Rauch M, Verdianz M, Attarbaschi A, Dworzak M, Peters C, Hammer K, Vecsei A, Pötschger U, Lion T. Fazekas T, et al. Among authors: lion t. J Pediatr Hematol Oncol. 2012 Aug;34(6):442-9. doi: 10.1097/MPH.0b013e3182580bc8. J Pediatr Hematol Oncol. 2012. PMID: 22767134 Clinical Trial.
Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy.
Salmon M, White HE, Zizkova H, Gottschalk A, Motlova E, Cerveira N, Colomer D, Coriu D, Franke GN, Gottardi E, Izzo B, Jurcek T, Lion T, Schäfer V, Venturi C, Vigneri P, Zawada M, Zuna J, Hovorkova L, Koblihova J, Klamova H, Markova MS, Srbova D, Benesova A, Polivkova V, Zackova D, Mayer J, Roeder I, Glauche I, Ernst T, Hochhaus A, Polakova KM, Cross NCP. Salmon M, et al. Among authors: lion t. Leukemia. 2022 Jul;36(7):1879-1886. doi: 10.1038/s41375-022-01612-2. Epub 2022 Jun 8. Leukemia. 2022. PMID: 35676453 Free PMC article.
199 results